Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/03/2022* -- Results Q2 2022 -- 2.09 --
08/03/2022* 17:00 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q1 2022 1.61 1.87 -13.78%
05/05/2022 17:00 EST Earnings Call Q1 2022 -- -- --
02/10/2022 -- Results Q4 2021 2.02 1.80 12.27%
02/10/2022 17:00 EST Earnings Call Q4 2021 -- -- --
10/28/2021 -- Results Q3 2021 2.36 2.26 4.61%
10/28/2021 17:00 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/03/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/05/2022
Beat/Miss Upgrade
Return Since -8.88%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
URL https://www.davita.com
Investor Relations URL https://investors.davita.com
HQ State/Province Colorado
Sector Healthcare
Industry Medical Care Facilities
Equity Style Mid Cap/Value
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-7.96%
-7.90%
12.54%
-28.78%
45.80%
56.47%
-3.10%
-14.35%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-14.35%
15.15%
14.57%
36.77%
-22.39%
-37.74%
19.55%
-34.54%
-2.68%
-35.26%
76.77%
60.66%
-32.12%
-18.00%
-3.71%
34.97%
22.20%
--
-22.65%
-23.66%
-19.09%
59.91%
85.31%
84.11%
-25.54%
--
--
--
--
--
--
--
-14.87%
As of May 26, 2022.

Profile

Edit
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
URL https://www.davita.com
Investor Relations URL https://investors.davita.com
HQ State/Province Colorado
Sector Healthcare
Industry Medical Care Facilities
Equity Style Mid Cap/Value
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
LMBHX 5.811M USD 2.39%
CHO108 2.444M USD 1.81%
FSHCX 21.05M USD 1.59%
SPGP 13.56M USD 1.55%
GTLIX 19.76M USD 1.51%
KCEIX 684089.0 USD 1.42%
WTV 1.373M USD 1.26%
IHF 15.59M USD 1.01%
YPS 153910.0 USD 0.61%
SAUMX 922012.0 USD 0.29%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter DVA Tweets